SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 90 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $849,000 | -61.2% | 50,000 | -75.0% | 0.89% | -51.4% |
| Q2 2014 | $2,190,000 | -20.1% | 200,000 | -34.8% | 1.84% | +2.4% |
| Q1 2014 | $2,742,000 | -68.4% | 306,735 | -73.3% | 1.79% | -71.8% |
| Q4 2013 | $8,677,000 | +1.5% | 1,150,745 | -1.3% | 6.37% | -14.8% |
| Q3 2013 | $8,545,000 | +13.4% | 1,165,745 | -0.6% | 7.47% | +36.7% |
| Q2 2013 | $7,538,000 | – | 1,172,314 | – | 5.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |